Rabbit Polyclonal MAZ antibody. Suitable for IHC-P, IP, WB and reacts with Human samples. Cited in 3 publications. Immunogen corresponding to Synthetic Peptide within Human MAZ aa 400 to C-terminus.
pH: 7 - 8
Preservative: 0.09% Sodium azide
Constituents: Tris buffered saline, 0.1% BSA
IHC-P | IP | WB | |
---|---|---|---|
Human | Tested | Tested | Tested |
Mouse | Predicted | Predicted | Predicted |
Rat | Predicted | Predicted | Predicted |
Chimpanzee | Predicted | Predicted | Predicted |
Chinese hamster | Predicted | Predicted | Predicted |
Guinea pig | Predicted | Predicted | Predicted |
Horse | Predicted | Predicted | Predicted |
Pig | Predicted | Predicted | Predicted |
Rabbit | Predicted | Predicted | Predicted |
Rhesus monkey | Predicted | Predicted | Predicted |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/500.00000 - 1/2000.00000 | Notes Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol. |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat, Rabbit, Horse, Guinea pig, Pig, Chimpanzee, Rhesus monkey, Chinese hamster | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 2.00000-5.00000 µg/mg of lysate | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat, Rabbit, Horse, Guinea pig, Pig, Chimpanzee, Rhesus monkey, Chinese hamster | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/2000.00000 - 1/10000.00000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat, Rabbit, Horse, Guinea pig, Pig, Chimpanzee, Rhesus monkey, Chinese hamster | Dilution info - | Notes - |
Transcriptional regulator, potentially with dual roles in transcription initiation and termination. Isoform 1. Binds DNA and functions as a transcriptional activator (PubMed:12270922). Binds to two G/A-rich sites, ME1a1 and ME1a2, within the MYC promoter having greater affinity for the former (PubMed:1502157). Also binds to multiple G/C-rich sites within the promoter of the Sp1 family of transcription factors (PubMed:1502157). Isoform 2. Binds DNA and functions as a transcriptional activator (PubMed:12270922). Inhibits MAZ isoform 1-mediated transcription (PubMed:12270922). Isoform 3. Binds DNA and functions as a transcriptional activator.
ZNF801, MAZ, Myc-associated zinc finger protein, MAZI, Pur-1, Purine-binding transcription factor, Serum amyloid A-activating factor-1, Transcription factor Zif87, ZF87, Zinc finger protein 801, SAF-1
Rabbit Polyclonal MAZ antibody. Suitable for IHC-P, IP, WB and reacts with Human samples. Cited in 3 publications. Immunogen corresponding to Synthetic Peptide within Human MAZ aa 400 to C-terminus.
pH: 7 - 8
Preservative: 0.09% Sodium azide
Constituents: Tris buffered saline, 0.1% BSA
The MAZ protein also known as Myc-associated zinc finger protein or Pur-1 has a mass of about 49 kDa. This protein is a transcription factor and contains zinc-finger motifs that enable it to bind to specific DNA sequences influencing gene expression. MAZ is expressed in various tissues including the brain and the heart and plays a significant role in regulating various physiological processes. Researchers often study MAZ for its involvement in cellular proliferation and differentiation.
MAZ influences the transcription of genes involved in cell growth and division. It does not function as part of a larger complex but acts by binding directly to DNA influencing the transcription machinery. Its activity is critical in controlling genes linked to cell cycle progression and apoptosis. Its regulatory functions help maintain normal cellular function and tissue homeostasis.
MAZ is integral to the regulation of the MAPK and Wnt signaling pathways. The protein interacts with other signaling molecules in these pathways to modulate gene expression linked to cell proliferation and differentiation. Additionally MAZ has associations with the MYC oncogene highlighting its involvement in pathways related to cellular growth and cancer development.
Researchers find a relationship between MAZ and cancer especially glioblastoma and colorectal cancer. The protein's overexpression can contribute to oncogenic transformation and tumor progression. MAZ also connects with other proteins such as MYC in these disorders highlighting its important role in cancer-related pathways. Understanding the role of MAZ in these diseases could provide insights into therapeutic targets for limiting tumor growth.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human prostate carcinoma tissue labelling MAZ with ab85725 at 1/1000 (1μg/mL). Detection: DAB.
Detection of Human MAZ by Immunoprecipitation in HeLa cell lysate (1 mg for IP, 20% of IP loaded) using ab85725 at 3 ug/mg lysate from HeLa cells (lane 1). Lane 2 is Control IgG IP. Subsequent WB detection was performed using 1 ug/ml ab85725. Detection:
Chemiluminescence with exposure times of 30 seconds.
All lanes: Immunoprecipitation - Anti-MAZ antibody (ab85725)
Predicted band size: 49 kDa
All lanes: Western blot - Anti-MAZ antibody (ab85725) at 0.1 µg/mL
Lane 1: HeLa cells lysate at 50 µg
Lane 2: HeLa cells lysate at 15 µg
Lane 3: HeLa cells lysate at 5 µg
Developed using the ECL technique.
Predicted band size: 49 kDa
Observed band size: 35 kDa, 39 kDa, 60 kDa
Exposure time: 30s
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com